Literature DB >> 18626746

A structural insight into CK2 inhibition.

Marco Mazzorana1, Lorenzo A Pinna, Roberto Battistutta.   

Abstract

The acidophilic Ser/Thr protein kinase CK2 displays some unique properties such as high pleiotropicity and constitutive activity. CK2 is involved in many fundamental aspects of the normal cell life, for instance it promotes cell survival and enhances the tumour phenotype under special circumstances. This makes CK2 an appealing target for the development of inhibitors with pharmacological potential. Here we present an overview of our recent studies on inhibitors directed to the CK2 ATP-binding site whose distinctive features are highlighted by the ability to use both ATP and GTP as co-substrates and by its low susceptibility to staurosporine inhibition. We discuss the effects of the binding of different chemical families of fairly selective inhibitors with potency in the nanomolar or low micromolar range. An important common energetic contribution to the binding is due to the hydrophobic interaction with the apolar surface region of the CK2 binding cleft. The analysis of the known CK2 crystal structures reveals the presence of some highly conserved water molecules in this region. These waters reside near Lys68, in an area with a positive electrostatic potential that is able to attract and orient negatively charged ligands. The presence of this positive region and of two unique bulky residues, Ile66 and Ile174, responsible for the reduced dimension of the CK2 active site, play a critical role in determining ligand orientation and binding selectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18626746     DOI: 10.1007/s11010-008-9822-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  GTP plus water mimic ATP in the active site of protein kinase CK2.

Authors:  K Niefind; M Pütter; B Guerra; O G Issinger; D Schomburg
Journal:  Nat Struct Biol       Date:  1999-12

2.  Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight.

Authors:  Erika De Moliner; Stefano Moro; Stefania Sarno; Giuseppe Zagotto; Giuseppe Zanotti; Lorenzo A Pinna; Roberto Battistutta
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

Review 3.  Protein kinase CK2: a challenge to canons.

Authors:  Lorenzo A Pinna
Journal:  J Cell Sci       Date:  2002-10-15       Impact factor: 5.285

Review 4.  CK2 as a positive regulator of Wnt signalling and tumourigenesis.

Authors:  David C Seldin; Esther Landesman-Bollag; Marganit Farago; Nicolas Currier; David Lou; Isabel Dominguez
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

5.  Protein kinase CK2 mutants defective in substrate recognition. Purification and kinetic analysis.

Authors:  S Sarno; P Vaglio; F Meggio; O G Issinger; L A Pinna
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

6.  Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.

Authors:  M A Kelliher; D C Seldin; P Leder
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

Review 7.  Targeting CK2 for cancer therapy.

Authors:  Kashif A Ahmad; Guixia Wang; Joel Slaton; Gretchen Unger; Khalil Ahmed
Journal:  Anticancer Drugs       Date:  2005-11       Impact factor: 2.248

8.  Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2.

Authors:  F Meggio; A Donella Deana; M Ruzzene; A M Brunati; L Cesaro; B Guerra; T Meyer; H Mett; D Fabbro; P Furet
Journal:  Eur J Biochem       Date:  1995-11-15

9.  Casein kinase II alpha transgene-induced murine lymphoma: relation to theileriosis in cattle.

Authors:  D C Seldin; P Leder
Journal:  Science       Date:  1995-02-10       Impact factor: 47.728

10.  The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks.

Authors:  Joanna I Loizou; Sherif F El-Khamisy; Anastasia Zlatanou; David J Moore; Douglas W Chan; Jun Qin; Stefania Sarno; Flavio Meggio; Lorenzo A Pinna; Keith W Caldecott
Journal:  Cell       Date:  2004-04-02       Impact factor: 41.582

View more
  14 in total

Review 1.  Structural and functional determinants of protein kinase CK2α: facts and open questions.

Authors:  Roberto Battistutta; Graziano Lolli
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

2.  A detailed thermodynamic profile of cyclopentyl and isopropyl derivatives binding to CK2 kinase.

Authors:  Takayoshi Kinoshita; Yusuke Sekiguchi; Harumi Fukada; Tetsuko Nakaniwa; Toshiji Tada; Shinya Nakamura; Kazuo Kitaura; Hiroaki Ohno; Yamato Suzuki; Akira Hirasawa; Isao Nakanishi; Gozoh Tsujimoto
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

3.  Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.

Authors:  Janeen H Trembley; Gretchen M Unger; Vicci L Korman; Diane K Tobolt; Zygmunt Kazimierczuk; Lorenzo A Pinna; Betsy T Kren; Khalil Ahmed
Journal:  Cancer Lett       Date:  2011-10-12       Impact factor: 8.679

4.  Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Authors:  Simone Fabbian; Gabriele Giachin; Massimo Bellanda; Christian Borgo; Maria Ruzzene; Giacomo Spuri; Ambra Campofelice; Laura Veneziano; Marcella Bonchio; Mauro Carraro; Roberto Battistutta
Journal:  Front Mol Biosci       Date:  2022-06-02

5.  Structural basis for decreased affinity of Emodin binding to Val66-mutated human CK2 alpha as determined by molecular dynamics.

Authors:  Na Zhang; Rugang Zhong
Journal:  J Mol Model       Date:  2009-10-11       Impact factor: 1.810

6.  Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α.

Authors:  Paul Brear; Darby Ball; Katherine Stott; Sheena D'Arcy; Marko Hyvönen
Journal:  J Med Chem       Date:  2020-10-29       Impact factor: 7.446

7.  Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A.

Authors:  Stefania Sarno; Marco Mazzorana; Ryan Traynor; Maria Ruzzene; Giorgio Cozza; Mario A Pagano; Flavio Meggio; Giuseppe Zagotto; Roberto Battistutta; Lorenzo A Pinna
Journal:  Cell Mol Life Sci       Date:  2011-07-01       Impact factor: 9.261

8.  Specific phosphorylation of the PfRh2b invasion ligand of Plasmodium falciparum.

Authors:  Klemens Engelberg; Aditya S Paul; Boris Prinz; Maya Kono; Wilhelm Ching; Dorothee Heincke; Thomas Dobner; Tobias Spielmann; Manoj T Duraisingh; Tim-Wolf Gilberger
Journal:  Biochem J       Date:  2013-06-15       Impact factor: 3.857

9.  Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.

Authors:  Laszlo Gyenis; James S Duncan; Jacob P Turowec; Maria Bretner; David W Litchfield
Journal:  J Proteome Res       Date:  2011-10-13       Impact factor: 4.466

10.  Synthesis of Novel Halogenated Heterocycles Based on o-Phenylenediamine and Their Interactions with the Catalytic Subunit of Protein Kinase CK2.

Authors:  Maria Winiewska-Szajewska; Agnieszka Monika Maciejewska; Elżbieta Speina; Jarosław Poznański; Daniel Paprocki
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.